Jose F Rojas

This inventor holds 13 USPTO granted patents and 6 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignees: Regeneron Pharmaceuticals, Inc., Regeneran Pharmaceuticals, Inc.. Active years: 2015-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jose F Rojas. Retrieved from https://idiyas.com/inventor/jose-f-rojas

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 13 (Patent Applications = 6)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 45(Granted Patents)

Company Filing History:

11 out of 1,484

Regeneron Pharmaceuticals, Inc.

patents

2 out of 49

Regeneran Pharmaceuticals, Inc.

patents

Years Active: 2015-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12369570 - Humanized IL-15 animals (2025-07-29),

2. 12250931 - Genetically modified mouse with a humanized PNPLA3 gene and methods of use (2025-03-18),

3. 11932859 - Nuclease-mediated DNA assembly (2024-03-19),

4. 11503813 - Humanized IL-15 animals (2022-11-22),

5. 11499164 - Methods for scarless introduction of targeted modifications into targeting vectors (2022-11-15),

6. 11470828 - Rodent model of mood disorders (2022-10-18),

7. 11111504 - Methods for scarless introduction of targeted modifications into targeting vectors (2021-09-07),

8. 10626402 - Nuclease-mediated DNA assembly (2020-04-21),

9. 10561125 - Humanized IL-15 animals (2020-02-18),

10. 10273488 - Nuclease-mediated DNA assembly (2019-04-30),

11. 9738897 - Nuclease-mediated DNA assembly (2017-08-22),

12. 9580715 - Nuclease-mediated DNA assembly (2017-02-28),

13. 9155290 - Humanized IL-15 animals (2015-10-13),

Title: The Innovative Contributions of Jose F Rojas

Introduction

Jose F Rojas is a prominent inventor based in Newburgh, NY (US), known for his significant contributions to the field of genetic engineering. With a total of 13 patents to his name, Rojas has made remarkable advancements in the development of genetically modified organisms, particularly in the context of humanized interleukin-15 and PNPLA3 genes.

Latest Patents

Rojas's latest patents include groundbreaking work on humanized IL-15 animals. These genetically modified non-human animals comprise a humanized interleukin-15 (IL-15) gene, which has implications for various biomedical applications. Additionally, he has developed cells, embryos, and non-human animals that express human IL-15 protein. Another notable patent involves a genetically modified mouse with a humanized PNPLA3 gene. This innovation provides methods for using non-human animals to assess the in vivo efficacy of human-PNPLA3-targeting reagents, such as nuclease agents designed to target human PNPLA3.

Career Highlights

Throughout his career, Rojas has worked with leading companies in the biotechnology sector, including Regeneron Pharmaceuticals, Inc. and Regeneron Pharmaceuticals, Inc. His work has been instrumental in advancing the understanding of genetic modifications and their applications in medicine.

Collaborations

Rojas has collaborated with notable colleagues, including Ka-Man Venus Lai and Andrew J Murphy. These partnerships have contributed to the success of his innovative projects and the advancement of genetic research.

Conclusion

Jose F Rojas stands out as a key figure in the field of genetic engineering, with a strong portfolio of patents that reflect his innovative spirit and dedication to scientific advancement. His work continues to influence the landscape of biotechnology and genetic research.

Profile summary based on public USPTO records.